These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 11572549)

  • 1. Evidence-based advertising?
    Replogle WH
    J Am Board Fam Pract; 2001; 14(5):399. PubMed ID: 11572549
    [No Abstract]   [Full Text] [Related]  

  • 2. Pharmaceutical advertising in the Journal.
    Pierach CA
    N Engl J Med; 1992 Dec; 327(23):1688-9. PubMed ID: 1435912
    [No Abstract]   [Full Text] [Related]  

  • 3. Pharmaceutical advertising in the Journal.
    Glass AR
    N Engl J Med; 1992 Dec; 327(23):1688; author reply 1689. PubMed ID: 1435911
    [No Abstract]   [Full Text] [Related]  

  • 4. Advertising standards.
    Drug Ther Bull; 2013 Jul; 51(7):73. PubMed ID: 23842632
    [No Abstract]   [Full Text] [Related]  

  • 5. Pharmaceutical ads in journals.
    Liebman M
    Ann Intern Med; 1992 Oct; 117(7):617; author reply 618-9. PubMed ID: 1524341
    [No Abstract]   [Full Text] [Related]  

  • 6. Pharmaceutical ads in journals.
    Beary JF
    Ann Intern Med; 1992 Oct; 117(7):616; author reply 618-9. PubMed ID: 1524338
    [No Abstract]   [Full Text] [Related]  

  • 7. Responsibility in advertising.
    Mann E
    CMAJ; 2003 Mar; 168(6):673; discussion 673, 675. PubMed ID: 12642416
    [No Abstract]   [Full Text] [Related]  

  • 8. Evidence based advertising? Half of drug advertisements in BMJ over six months cited no supporting evidence.
    Smart S; Williams C
    BMJ; 1997 Dec; 315(7122):1622-3. PubMed ID: 9437302
    [No Abstract]   [Full Text] [Related]  

  • 9. Traveling medicine shows: a modern update?
    Carroll-Johnson RM
    Oncol Nurs Forum; 1992 Oct; 19(9):1315. PubMed ID: 1437666
    [No Abstract]   [Full Text] [Related]  

  • 10. Advertising and clinical investigation.
    Ciaglia P; Levy H; Ryan TF
    Chest; 1990 Nov; 98(5):1309-10. PubMed ID: 2225998
    [No Abstract]   [Full Text] [Related]  

  • 11. [Misleading advertisement of Adalat Oros].
    Verheugt FW
    Ned Tijdschr Geneeskd; 2001 Sep; 145(36):1751-2. PubMed ID: 11572178
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug advertising in medical journals.
    Vilardell M
    Lancet; 2003 Mar; 361(9360):879. PubMed ID: 12642075
    [No Abstract]   [Full Text] [Related]  

  • 13. Drug advertising.
    Bell KD
    Med J Aust; 1987 Oct; 147(7):361. PubMed ID: 3657662
    [No Abstract]   [Full Text] [Related]  

  • 14. A stand against drug company advertising.
    Jelinek GA; Brown AF
    Emerg Med Australas; 2011 Feb; 23(1):4-6. PubMed ID: 21284808
    [No Abstract]   [Full Text] [Related]  

  • 15. Communication and public health: a question of scope or readership?
    White M
    J Public Health Med; 1991 Nov; 13(4):360. PubMed ID: 1764300
    [No Abstract]   [Full Text] [Related]  

  • 16. Pharmaceutical ads in journals.
    Noble RC
    Ann Intern Med; 1992 Oct; 117(7):617-8. PubMed ID: 1307693
    [No Abstract]   [Full Text] [Related]  

  • 17. [Misleading advertisement of Adalat Oros].
    Cleophas TJ
    Ned Tijdschr Geneeskd; 2002 Jan; 146(2):88-9. PubMed ID: 11820065
    [No Abstract]   [Full Text] [Related]  

  • 18. Pressing questions.
    Sheppard B
    Paediatr Nurs; 1998 May; 10(4):7. PubMed ID: 9687777
    [No Abstract]   [Full Text] [Related]  

  • 19. Commentary: advertising adversities.
    Christo GG; Balasubramaniam R
    BMJ; 1997 Aug; 315(7106):460. PubMed ID: 9284663
    [No Abstract]   [Full Text] [Related]  

  • 20. Drug company-sponsored symposia: pros and cons.
    Finucane T
    Am J Med; 1987 Oct; 83(4):811-2. PubMed ID: 3674075
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.